American Healthcare REIT (AHR) Nareit REITweek: 2026 Investor Conference summary
Event summary combining transcript, slides, and related documents.
Nareit REITweek: 2026 Investor Conference summary
2 Jun, 2026Strategic focus and growth
Capital allocation is centered on managed care through two RIDEA segments: Traditional SHOP and Trilogy, which together account for about 80% of NOI and are growing rapidly.
Internal growth has led to industry-leading FFO per share growth of 20%+ for nine consecutive quarters, while net debt to EBITDA has been reduced to 3x.
The awarded investment pipeline has expanded from $650 million to over $1 billion, prompting a recent capital raise to support further acquisitions.
Expansion is focused on existing operators, with $250 million closed year-to-date and the pipeline entirely with established partners.
The company is positioned to benefit from strong sector fundamentals, with high demand and limited supply driving a multi-year growth outlook.
Acquisition and portfolio strategy
Emphasis is placed on partnering with high-quality operators, prioritizing operator quality over market or asset characteristics.
Most pipeline deals are smaller, allowing for targeted, incremental growth and regional density.
Larger portfolio acquisitions are only pursued when there is significant overlap with preferred operators or strategic markets.
SHOP portfolio skews toward assisted living, with strong operator relationships and embedded growth expected to drive same-store NOI growth in 2026 and 2027.
Recent acquisitions have focused on high-quality, Class A assets in strong markets, with a heavy weighting toward higher-acuity care.
Trilogy model and development approach
Trilogy operates about 150 buildings with a unique full-continuum-of-care campus model, integrating IL, AL, memory care, and skilled nursing.
Development is limited to three to five new campuses per year to avoid diluting operational focus and maintain high performance across the portfolio.
Trilogy’s purpose-built campuses enable seamless resident transitions and high operational efficiency, supporting predictable returns.
NOI margins for Trilogy are above 20%, with occupancy over 91%; margin flow-through is moderated by the needs-based, care-intensive nature of the business.
The integrated model and limited new supply in skilled nursing create a strong competitive moat and long-term demand tailwinds.
Latest events from American Healthcare REIT
- Double-digit NOI and NFFO growth in 2025, with strong 2026 outlook and robust acquisition pipeline.AHR
Q4 20259 Jul 2026 - Trilogy buyout, strong NOI/FFO growth, and raised guidance mark a transformative Q3.AHR
Q3 20248 Jul 2026 - Raised 2025 guidance after 15.1% same-store NOI growth and strong SHOP/ISHC performance.AHR
Q1 20258 Jul 2026 - Strong demand, limited supply, and operator focus drive multi-year growth and raised 2025 guidance.AHR
Nareit REITweek: 2025 Investor Conference8 Jul 2026 - Double-digit NOI and FFO growth drive raised 2026 guidance and strong Q1 results.AHR
Q1 20268 May 2026 - Strong demand, limited supply, and operator alignment drive robust growth in senior housing.AHR
Citi’s Miami Global Property CEO Conference 202629 Apr 2026 - Q3 2025 net income hit $56.6M with 16.4% NOI growth and raised 2025 guidance.AHR
Q3 202523 Apr 2026 - Proxy covers director elections, auditor ratification, and strong 2025 performance with 80% TSR.AHR
Proxy filing9 Apr 2026 - Double-digit NOI growth and strong occupancy highlight robust performance and future growth potential.AHR
Investor presentation2 Mar 2026